AI Funding

Top News

AstraZeneca's $555 Million AI-Powered Gene-Editing Deal

AstraZeneca's $555 Million AI-Powered Gene-Editing Deal with Algen Biotechnologies

AstraZeneca signs a $555 million deal with Algen Biotechnologies to develop AI-driven gene-editing therapies, marking a significant step in the pharmaceutical industry's adoption of AI for drug discovery.

Technology2 sources
Prev1…51525354Next
Organisationarrow_forward
OpenAIGoogleAnthropicMicrosoftMetaNvidiaApple
Peoplearrow_forward
Sam AltmanJensen HuangElon MuskSundar PichaiSatya NadellaMark zuckerbergDario Amodei
Productarrow_forward
ChatGPTGeminiClaudeCopilotGrokDeepSeekAndroid
LLM Modelarrow_forward
GPTClaudeGeminiLlamaGrokDeepSeekNanoBanana
Eventarrow_forward
Google I/OWWDCMicrosoft BuildNVIDIA GTCMWCNeurIPSCES
Conceptarrow_forward
Agentic AILLMsAGIAI safetyRAGVibe CodingAI regulation
Industryarrow_forward
FinTechRoboticsCybersecurityGamingLegalMediaAI learning
Geoarrow_forward
United StatesChinaEuropeIndiaUnited KingdomJapanMiddle East
TheOutpost.ai

Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Follow topics that matter to you and stay ahead.

Instagram logo
LinkedIn logo
Youtube logo
Explore
Top StoriesPodcastsNewsletterBlogArchivesAbout us
News Categories
TechnologyBusinessPolicyStartupsHealthScienceEntertainment
© 2026 TheOutpost.AI All rights reserved
TermsPrivacyContentContact Us